217 related articles for article (PubMed ID: 23588948)
21. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
[TBL] [Abstract][Full Text] [Related]
22. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.
Sun CY; Zang YC; San YX; Sun W; Zhang L
Saudi Med J; 2010 May; 31(5):525-32. PubMed ID: 20464042
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic PAR-3 protein expression is associated with adverse prognostic factors in clear cell renal cell carcinoma and independently impacts survival.
Dagher J; Dugay F; Rioux-Leclercq N; Verhoest G; Oger E; Bensalah K; Cabillic F; Jouan F; Kammerer-Jacquet SF; Fergelot P; Vigneau C; Arlot-Bonnemains Y; Belaud-Rotureau MA
Hum Pathol; 2014 Aug; 45(8):1639-46. PubMed ID: 24856572
[TBL] [Abstract][Full Text] [Related]
24. Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer.
Dahinden C; Ingold B; Wild P; Boysen G; Luu VD; Montani M; Kristiansen G; Sulser T; Bühlmann P; Moch H; Schraml P
Clin Cancer Res; 2010 Jan; 16(1):88-98. PubMed ID: 20028743
[TBL] [Abstract][Full Text] [Related]
25. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
[TBL] [Abstract][Full Text] [Related]
26. Prognostic implication of TIM-3 in clear cell renal cell carcinoma.
Yuan J; Jiang B; Zhao H; Huang Q
Neoplasma; 2014; 61(1):35-40. PubMed ID: 24195506
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of Dkk1 and Dkk3 in human clear cell renal cell carcinoma.
Guo CC; Zhang XL; Yang B; Geng J; Peng B; Zheng JH
Mol Med Rep; 2014 Jun; 9(6):2367-73. PubMed ID: 24676838
[TBL] [Abstract][Full Text] [Related]
28. Low level of PDZ domain containing 1 (PDZK1) predicts poor clinical outcome in patients with clear cell renal cell carcinoma.
Zheng J; Wang L; Peng Z; Yang Y; Feng D; He J
EBioMedicine; 2017 Feb; 15():62-72. PubMed ID: 27993630
[TBL] [Abstract][Full Text] [Related]
29. Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype.
Vilella-Arias SA; Rocha RM; da Costa WH; Zequi Sde C; Guimarães GC; Verjovski-Almeida S; Soares FA; Reis EM
Urology; 2013 Oct; 82(4):974.e1-7. PubMed ID: 23920448
[TBL] [Abstract][Full Text] [Related]
30. SERPINH1 overexpression in clear cell renal cell carcinoma: association with poor clinical outcome and its potential as a novel prognostic marker.
Qi Y; Zhang Y; Peng Z; Wang L; Wang K; Feng D; He J; Zheng J
J Cell Mol Med; 2018 Feb; 22(2):1224-1235. PubMed ID: 29239102
[TBL] [Abstract][Full Text] [Related]
31. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.
Vieira de Ribeiro AJ; Sandim V; Ornellas AA; Reis RS; Domont G; Alves G
Int Braz J Urol; 2013; 39(1):83-94. PubMed ID: 23510786
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of ERK1/2 and prognosis of clear cell renal cell carcinoma.
Lee HJ; Kim DI; Kang GH; Kwak C; Ku JH; Moon KC
Urology; 2009 Feb; 73(2):394-9. PubMed ID: 18849062
[TBL] [Abstract][Full Text] [Related]
33. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
[TBL] [Abstract][Full Text] [Related]
34. [Expression and role of vascular endothelial growth inhibitor in sporadic clear cell renal cell carcinoma].
Wu LY; Cheng H; Deng XH; Shan H; Wang W; Yang Y; Zhang XD; Zhang N
Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):741-5. PubMed ID: 23755810
[TBL] [Abstract][Full Text] [Related]
35. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
36. CD151 expression can predict cancer progression in clear cell renal cell carcinoma.
Yoo SH; Lee K; Chae JY; Moon KC
Histopathology; 2011 Jan; 58(2):191-7. PubMed ID: 21323946
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma.
Ye YW; Jiang ZM; Li WH; Li ZS; Han YH; Sun L; Wang Y; Xie J; Liu YC; Zhao J; Tang AF; Li XX; Guan ZC; Gui YT; Cai ZM
Neoplasma; 2012; 59(6):599-605. PubMed ID: 22862160
[TBL] [Abstract][Full Text] [Related]
38. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.
Rabjerg M; Oliván-Viguera A; Hansen LK; Jensen L; Sevelsted-Møller L; Walter S; Jensen BL; Marcussen N; Köhler R
PLoS One; 2015; 10(4):e0122992. PubMed ID: 25848765
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
[TBL] [Abstract][Full Text] [Related]
40. [Expression of oxidative stress proteins in the clear-cell renal cell carcinoma].
Tian MJ; Li YY; Luo CQ; Lv ML; Yang J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):851-5. PubMed ID: 22863595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]